#TITLE_ALTERNATIVE#
Impurities in pharmaceutical products are compounds that could be degradant from the drugs or <br /> <br /> excipients, or compounds resulted from the reaction between drugs with excipients or others. <br /> <br /> Piroxicam has many impurities that can affect quality, ef...
Saved in:
Main Author: | |
---|---|
Format: | Final Project |
Language: | Indonesia |
Subjects: | |
Online Access: | https://digilib.itb.ac.id/gdl/view/25831 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Institut Teknologi Bandung |
Language: | Indonesia |
id |
id-itb.:25831 |
---|---|
spelling |
id-itb.:258312018-03-06T09:18:19Z#TITLE_ALTERNATIVE# WIGUNA, ARVIN Farmakologi dan terapeutik Indonesia Final Project INSTITUT TEKNOLOGI BANDUNG https://digilib.itb.ac.id/gdl/view/25831 Impurities in pharmaceutical products are compounds that could be degradant from the drugs or <br /> <br /> excipients, or compounds resulted from the reaction between drugs with excipients or others. <br /> <br /> Piroxicam has many impurities that can affect quality, efficacy and safety. This study aims to <br /> <br /> develop a method to analyze contaminants of piroxicam using thin layer chromatography - <br /> <br /> densitometry. The study was began with piroxicam exposure in stress condition, and then <br /> <br /> optimizing eluent composition that can separate piroxicam and its impurity well. Following with <br /> <br /> system suitability test with repeatability and resolution as the parameters is tested. The method <br /> <br /> was validated with linearity, limit of detection, limit of quantification, accuracy, and precision as <br /> <br /> the parameter. From linearity parameter, the regression equation is y = 1097,91 + 856,73x and <br /> <br /> the correlation coefficient is 0,9997. From accuracy parameter the result for recovery test at 16, <br /> <br /> 20, and 24 ?g/spot is 100,49%, 99,97%, and 99,59%. The result coefficient variation from <br /> <br /> precision intraday test is 0,23% and from precision interday test is 0,23%, 1,31%, and 0,75%. <br /> <br /> After the method was validated, the piroxicam content after degradation and ratio between <br /> <br /> piroxicam and its impurity was measured. Then the piroxicam content in capsule and gel from <br /> <br /> commercial products was measured. The result is piroxicam content in capsule is 99,1% and in <br /> <br /> gel is 96,95%. The result showed that analytical method using TLC - densitometry is validated and <br /> <br /> can analyze the impurity of piroxicam in commecial pharmaceutical products. <br /> text |
institution |
Institut Teknologi Bandung |
building |
Institut Teknologi Bandung Library |
continent |
Asia |
country |
Indonesia Indonesia |
content_provider |
Institut Teknologi Bandung |
collection |
Digital ITB |
language |
Indonesia |
topic |
Farmakologi dan terapeutik |
spellingShingle |
Farmakologi dan terapeutik WIGUNA, ARVIN #TITLE_ALTERNATIVE# |
description |
Impurities in pharmaceutical products are compounds that could be degradant from the drugs or <br />
<br />
excipients, or compounds resulted from the reaction between drugs with excipients or others. <br />
<br />
Piroxicam has many impurities that can affect quality, efficacy and safety. This study aims to <br />
<br />
develop a method to analyze contaminants of piroxicam using thin layer chromatography - <br />
<br />
densitometry. The study was began with piroxicam exposure in stress condition, and then <br />
<br />
optimizing eluent composition that can separate piroxicam and its impurity well. Following with <br />
<br />
system suitability test with repeatability and resolution as the parameters is tested. The method <br />
<br />
was validated with linearity, limit of detection, limit of quantification, accuracy, and precision as <br />
<br />
the parameter. From linearity parameter, the regression equation is y = 1097,91 + 856,73x and <br />
<br />
the correlation coefficient is 0,9997. From accuracy parameter the result for recovery test at 16, <br />
<br />
20, and 24 ?g/spot is 100,49%, 99,97%, and 99,59%. The result coefficient variation from <br />
<br />
precision intraday test is 0,23% and from precision interday test is 0,23%, 1,31%, and 0,75%. <br />
<br />
After the method was validated, the piroxicam content after degradation and ratio between <br />
<br />
piroxicam and its impurity was measured. Then the piroxicam content in capsule and gel from <br />
<br />
commercial products was measured. The result is piroxicam content in capsule is 99,1% and in <br />
<br />
gel is 96,95%. The result showed that analytical method using TLC - densitometry is validated and <br />
<br />
can analyze the impurity of piroxicam in commecial pharmaceutical products. <br />
|
format |
Final Project |
author |
WIGUNA, ARVIN |
author_facet |
WIGUNA, ARVIN |
author_sort |
WIGUNA, ARVIN |
title |
#TITLE_ALTERNATIVE# |
title_short |
#TITLE_ALTERNATIVE# |
title_full |
#TITLE_ALTERNATIVE# |
title_fullStr |
#TITLE_ALTERNATIVE# |
title_full_unstemmed |
#TITLE_ALTERNATIVE# |
title_sort |
#title_alternative# |
url |
https://digilib.itb.ac.id/gdl/view/25831 |
_version_ |
1822020815780052992 |